Startup · $180k raised
Detect cancer, for everyone, everywhere
Programs: Techstars Sydney (Techstars Sydney Accelerator)
Every investor coverage indicates participated in a round OncoRevive raised.
| Investor | Rounds | Invested |
|---|---|---|
| Techstars Sydney | Accelerator · Accelerator | - |
Companies OncoRevive acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
Stories naming OncoRevive. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Profile of OncoRevive, a startup whose blood test spots multiple cancer biomarkers in hours rather than weeks, written ahead of its Demo Day appearance with Techstars Sydney's 2025 cohort.
Weekly roundup covering 19 Australian and New Zealand raises, headlined by Andromeda Robotics' $23m Series A, plus Freckle, Marloo, X-Hemp, Harvest B, Wable, Starboard and Techstars Sydney's 12-startup cohort.
Also SmartCompany
Techstars Sydney's 2025 accelerator class holds 12 startups, with US$120,000 invested in each; seven are first-time funded. Supported by Investment NSW, the three-month Sydney program ends with a December Demo Day.